BM

Bhawna Mohnalal Hemrajani

Active Director Director DIN 09577675
DIN 09577675 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhawna Mohnalal Hemrajani

Data last updated:

Bhawna Mohnalal Hemrajani is a Director at Bluegill Remedies Private Limited (since 2022). The company operates in Chemicals.

DIN 09577675
Primary Designation Director
Industry Chemicals
First Appointment 19 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bluegill Remedies Private Limited U24239MH2022PTC380891
Director19 Apr 20222022Active

Board colleagues of Bhawna Mohnalal Hemrajani

NameDINCompanyDesignation
Cherry Mohan Hemrajani09577674Bluegill Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bluegill Remedies Private Limited
Premium access

Shareholding and investment profile for Bhawna Mohnalal Hemrajani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhawna Mohnalal Hemrajani

Bhawna Mohnalal Hemrajani currently holds 1 directorship: Bluegill Remedies Private Limited (Director, since 19 Apr 2022).

Bhawna Mohnalal Hemrajani was first appointed on 19 Apr 2022 as Director at Bluegill Remedies Private Limited.

The current boards of Bhawna Mohnalal Hemrajani's companies include Cherry Mohan Hemrajani (Bluegill Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available